The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.
Juan MoroteMiriam CampistolAnna CelmaLucas RegisInés de TorresMaría E SemideySarai RocheRichard MastAnna SantamariaJacques PlanasEnrique TrillaPublished in: The world journal of men's health (2021)
Proclarix is valuable in all men with suspected PCa. An algorithm integrating Proclarix score, serum PSA, and DRE can avoid mpMRI requests, unnecessary prostate biopsies and iPCa overdetection, with minimal loss of csPCa detection.